Odontogenic tumors are a heterogeneous group of lesions with variable clinical behavior.
INTRODUCTION
Odontogenic tumors (OT) consist of several lesions derived from tooth-forming apparatus presenting various histological, cytological, and architectural patterns. They range from hamartomatous lesions to true neoplasms (benign or malignant), exhibiting distinct clinical behaviors [1] [2] [3] . In order to better comprehend these lesions, facilitate communication between physicians and improve treatment, the World Health Organization (WHO) developed a classification system for OT in 1971. The edition (2005) highlights their histological types and biological behaviors, by dividing them in groups 4 .Some re-organizations made along the WHO classifications result in great divergences between authors. The inclusion of KCOT and CCOT as OT, formerly considered cysts, is one of the most controversial discussions. Several papers published after the 2005 WHO classification maintains considering KCOT and CCOT as cysts, not including them in OT studies 5, 6 . This leads to different epidemiological profiles of cysts and OT 3, 7, 8 . However in the WHO classification 2017 reconsidered his position and classified these lesions as odontogenic cysts 9 . Furthermore, previous studies show the prevalence of OT differs according to the geographical location; nevertheless, the lack of standardization concerning the edition of the WHO classification makes it necessary to better describe the frequency of these tumors. Thus, the objective of this study was to determine the global epidemiology of OT through a systematic search of the literature considering only studies based on the 2005 WHO classification.
MATERIAL AND METHODS
A systematic search was conducted in the PubMed/ Medline database for papers published from January 2006 to December 2016. Studies that evaluated the incidence and/or frequency of OT following the 2005 WHO classification were selected 4 . Entry terms included: "odontogenic tumors", "odontogenic tumours", "odontogenic lesions", "epidemiology" and "WHO classification", using the Boolean operators "AND" and "OR". The selected papers must have met the inclusion criteria described below:
• The paper must be full text and written in English;
• Incidence or frequency of OT must be described;
• 2005 WHO classification of head and neck tumors must be followed;
• Country or city where the study was conducted must be informed.
Case reports, papers that followed the 2005 WHO classification but excluded any type of tumor, and those that described the incidence of only one type of OT were not considered. For the initial selection, two independent evaluators screened titles and abstracts. We initially found 8,658 articles, after a critical analysis of abstracts, 495 articles were selected. Then, the papers judged pertinent were analyzed in their entirety and the 42 studies selected were defined in a consensus meeting and included in the systematization of the data (Figure 1) . Information regarding the geographic location, gender, age (categorized in decades of life), anatomical location, and histological type of tumor were recorded.
RESULTS
A total of 42 papers met the established criteria: 15 in Asia, 9 in South America, 9 in Africa, 6 in North America, 2 in Europe and 1 in Oceania (Table 1) . They described from 14 to 1,677 cases of OT and summed up, they accounted for 13,490 cases of OT. The majority of the studies was conducted in Asia (n=6,472; 48%) and the minority in Oceania (n=93; 0.7%). The most prevalent tumor worldwide was KCOT (n=4,328; 32.1%) followed by AMB (n=4,132; 30.6%) and ODO (n=2,339; 17.3%); however, in Asia and Africa AMB was more common (Figure 1 ). Since Turkey and Russia are transcontinental countries (Eurasia), Turkey was included in Asia as studies performed there were located in Southwestern Asia 43, 48 . No study was published in Russia. 
Tumors of odontogenic epithelium, without odontogenic ectomesenchyme
The most frequent tumors in this group were KCOT and AMB. Both occurred more in men, with a male/female ratio of 1.5:1 and 1.2:1, respectively. For the other tumors, women were more affected. Apart from AOT, the mandible was the most common anatomical site ( Table 2 ). The age of the patients ranged from 1 to 87 years and was more prevalent between the 2 nd and 4 th decades of life (Table 3) .
Tumors of odontogenic epithelium with odontogenic ectomesenchyme
ODO was by far the most frequent tumor in this group, occurring more in women, followed by CCOT, which was more common in men. Higher incidence in the mandible was observed, with the exception of ODA (Table 3) . The age ranged from 2 to 92 years and was more prevalent between the 1 st and 2 nd decades of life. CCOT, in particular, was more common between the 2 nd and 5 th decades (Table 3) . 
Tumors of mesenchyme and/or odontogenic ectomesenchyme, with or without odontogenic epithelium
The most frequent tumor in this group was MYX. Overall, all tumors occurred more in women and the mandible was the most common location ( Table 2 ). The age ranged from 3 to 83 years, being more prevalent between the 2 nd and 3 rd decades of life (Table 3) .
Malignant odontogenic tumors
Malignant OT represented only 4.3% of all tumors. MAMB was the most common tumor, followed by AMC. All malignant OT affected more men, with a male:female ratio of 1.6:1, and the mandible was the most common anatomical site ( Table 1 ). The age ranged from 7 to 82 years. Despite the wide age distribution, these tumors showed an increased incidence from the 4 th decade of life on (Table 4) .
DISCUSSION
OT are relatively uncommon lesions. Due to their various clinical and histological presentations, a better knowledge regarding their frequency is required. Data shows the frequency of OT differs according to the geographical location. Retrospective studies conducted in South America, North America and Europe show an incidence between 2.2% and 5% among all diagnosed oral lesions 3, 22, 29, 31 . On the other hand, in Africa 15 and Asia 16, 28 studies report a higher frequency, comprising up to 8.9% of all oral lesions.
In the present review, benign OT accounted for the majority of the cases (n=12,904; 95.7%) and malignant OT represented only 4.3% (n=586) of all tumors. Except for studies that only evaluated malignant OT 24, 37, 41, 42 , the overall incidence of these tumors range from 0 to 5.9% 8 7-23,25-36,38-40,43-48 , corroborating our data. Regarding the gender, most OT occurred in men. However, some studies in South America 3, 12, 32 , North America 17 and Asia 20 showed a higher incidence of these tumors in females. The age varied widely throughout the decades of life. In general, a higher prevalence between the 2 nd and 4 th decades of life was observed, according with other review papers 49, 50 . ODO and AFO were the exception, occurring more in the first and second decades of life. In contrast, malignant OT occurred more in older patients, with a peak incidence from the 4 th decade of life on, as also reported by Avelar et al. 49 and Johnson et al. 50 . Mandible was the main anatomical location with a mandible:maxilla ratio of approximately 2.8:1, similarly to other papers 49, 50 . Nevertheless, the studies performed in Africa 19, 21, 33, 34, 45 presented a higher mandible:maxilla ratio when compared to studies conducted in other continents, reaching up to 11:1.
KCOT was the most common neoplasm considering all OT. On the other hand, previous studies based on the 1971 and 1992 WHO classification 32, 49, 50 , aside from showing a smaller incidence of OT, they reported AMB and ODO as the most frequent tumors. Regardless of whether there is an agreement on the classification of this tumor, the fact is the inclusion of KCOT in the 2005 WHO classification, in addition to increase the overall frequency of OT, also led to a change in the epidemiological profile of these tumors worldwide 3, 8, 17 . Nevertheless, we emphasize that the KCOT was removed from the recent WHO classification of odontogenic tumors, it was once again classified as cyst, this fact certainly will lead to a different profile of global incidence from now on 9 .
In the Asian and African continent, despite the introduction of the tumors (KCOT and CCOT), AMB remains the most frequent tumor 11, 18, 19, 21, 23, 26, 28, 33, 36, 38, [43] [44] [45] [46] [47] . Besides that, globally, AMB currently represents the second most common OT diagnosed based on 2005 WHO classification.
The third most prevalent tumor was ODO. The low incidence of these tumors may happen because of underdiagnosed. The indolent behavior, self-limited growth and pathognomonic radiographic appearance lead many surgeons to perform their removal and discard them, not sending samples for histopathological analysis. Still, ODO was the most frequent tumor in some studies conducted in Europe 30 , North America 10 , South America 13, 27 , Asia 35 and Africa 14 . In relation to the malignant OT, MAMB was the most frequent one in our review. This tumor, also named as metastatic AMB, accounted for 31.4% of the malignant OT. Interestedly, North America was the only continent to report MAMB as the most common malignant tumor 42 . In the other continents, AMC followed by PIOSCC were more frequent. In this review, AMC was the second most common malignant neoplasm, representing 19.6% of all malignant OT. Concerning the diagnosis of MAMB, it may be difficult, as it does not present pleomorphism, necrosis, mitosis and other malignancy characteristics. Except for the ability to emit nodal and/ or distant metastasis, they are morphologically identical to a conventional AMB 4 . Because of this imprecise clinical and histopathological behavior, the recent WHO classification recategorized MAMB as a benign tumor, naming "Metastasizing (malignant) ameloblastoma" 9 . We consider this classification controversial, since the ability to emit metastasis is characteristic of cancer.
A single case in this review diagnosed as odontogenic carcinosarcoma was classified as unspecified malignant tumor, since the WHO (2005) excluded this tumor from the classification due to the absence of evidence as a separate entity from other odontogenic carcinomas 4, 35 . However, sclerosing odontogenic carcinoma and odontogenic carcinosarcoma has been added to the recent WHO classification 9 , although rare, the addition of these tumors will also change the incidence of malignant OT from now on.OT present different incidence profiles according to the geographical location, which became evident in this paper. The five main tumors diagnosed worldwide in descending order were: KCOT, AMB, ODO, MYX and AOT. However some odontogenic tumors are unreported. In addition, the incidence and frequency of these tumors are different when compared to studies based on the WHO classifications prior to 2005. There was a significant change with the addition of KCOT and CCOT in the 2005 WHO classification of head and neck tumors that led to an increase of approximately 35% in the total number of OT diagnosed to date.
